Vol. 3 No. 11 (2025), Articles
Vol. 3 No. 11 (2025)

PEG-INF ALFA-2B (ALGERON) VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH

Articles
Published 2025-11-20
Raimov Kamol Eshmo’minovich
Toshkent davlat tibbiyot universiteti Termiz filiali assistenti. Termez
PDF
DOI

How to Cite

PEG-INF ALFA-2B (ALGERON) VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH. (2025). Journal of Universal Science Research, 3(11), 184-185. https://universalpublishings.com/~niverta1/index.php/jusr/article/view/14578
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Surunkali delta gepatit (SDG) – gepatit B virusi (HBV) bilan birgalikda yuquvchi kasallik bo‘lib, jigar to‘qimasida og‘ir yallig‘lanish va fibroz jarayonlarini keltirib chiqaradigan kasallikdir. SDG dunyo bo‘yicha gepatitlar orasida eng xavfli va davolashda murakkab bo‘lgan turlaridan biri hisoblanadi.

PDF
DOI
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.